Revolution Medicines will present clinical data on its RAS(ON) inhibitor pipeline at the 2026 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress in Munich, Germany, from July 1–4, 2026. The company intends to showcase four presentations covering Phase 1/2 and Phase 3 trials for targeted therapies addressing RAS-addicted cancers, including pancreatic ductal adenocarcinoma (PDAC). … Read more
Why Collagen Supplements Are Trending in Wellness Routines Vital Proteins Collagen Peptides are currently seeing increased consumer interest as Amazon offers discounts of up to 30% during its Prime Day event. The product, which actor Jennifer Aniston has promoted as a Chief Creative Officer since 2020, currently holds a 4.6-star rating across nearly 70,000 reviews … Read more
Myriad Genetics has expanded the availability of its Precise MRD™ test to patients with breast, colorectal, and renal cancers, providing an ultrasensitive method for tracking circulating tumor DNA (ctDNA). According to the June 23, 2026, company announcement, the test uses whole-genome sequencing to monitor disease status across the cancer care continuum, potentially impacting the treatment … Read more
U.S. stocks are hovering near record highs as markets digest cooling oil prices and shifting expectations for Federal Reserve interest rate policy. While the S&P 500 recently pulled back 1.7% from its all-time high, Treasury yields continue to climb as traders anticipate potential rate hikes to combat inflation. According to AP News, the bond market … Read more
Federal health advisers have recommended approval for the first mRNA-based influenza vaccine, a move that could shift how the U.S. addresses seasonal flu. The Food and Drug Administration (FDA) is currently evaluating Moderna’s “mFlusiva” for adults ages 50 and older. If authorized, this vaccine would leverage the same messenger RNA technology used in COVID-19 shots … Read more
Beekeeper’s Naturals has issued a voluntary recall for 585 units of its Saline Nasal Spray after tests revealed microbiological contamination, including yeast and potential Aspergillus mold. According to a June 12, 2026, announcement posted on the Food and Drug Administration (FDA) website, the recalled products were sold on Amazon between April 2 and April 24, … Read more
The China National Medical Products Administration (NMPA) has approved Akeso, Inc.’s gumokimab (AK111) for the treatment of adult moderate-to-severe plaque psoriasis. According to the company, the monoclonal antibody demonstrated a 94.6% PASI 75 response rate and a 47.7% complete skin clearance rate (PASI 100) at Week 12. The drug is now poised to enter the … Read more
Visa has integrated its payment network directly into OpenAI’s ChatGPT, allowing the AI to autonomously execute consumer purchases. According to Visa, this partnership enables the chatbot to act as a digital agent that can locate products and complete transactions at any merchant accepting the Visa network, moving beyond the limited, retailer-specific experiments of the past. … Read more
Rakuten Medical has appointed Minami Maeda as its new full-time CEO, tasking him with accelerating the global rollout of the company’s Alluminox® photoimmunotherapy platform. The leadership transition, which elevates current CEO Mickey Mikitani to Executive Chairman, is designed to streamline decision-making as the firm prepares for upcoming U.S. regulatory filings and commercial expansion, according to … Read more
The Rise of the Humanoid: Can China’s Robotics Bet Pay Off? From the factory floor to the neighborhood hotel, the landscape of labor is shifting. China, long known as the “world’s factory,” is pivoting its massive manufacturing prowess toward a new frontier: the mass production of humanoid robots. While the global race for a $5 … Read more